A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.
Saved in:
| Title: | A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence. |
|---|---|
| Authors: | Silverberg, Jonathan I.1 (AUTHOR) jonathanisilverberg@gmail.com, Irvine, Alan D.2 (AUTHOR), Foley, Peter3 (AUTHOR), Del Rosso, James4 (AUTHOR), Puig, Luis5 (AUTHOR), Stein Gold, Linda6 (AUTHOR), Kamata, Masahiro7 (AUTHOR), Wollenberg, Andreas8,9,10 (AUTHOR), Hong, H. Chih-ho11,12 (AUTHOR), Chu, Chia-Yu13 (AUTHOR), Binamer, Yousef14,15 (AUTHOR), Dossenbach, Martin16 (AUTHOR), Casillas, Marta16 (AUTHOR), Gallo, Gaia16 (AUTHOR), Akmaz, Buelent17 (AUTHOR), Rand, Kim18 (AUTHOR), Chovatiya, Raj19,20 (AUTHOR) |
| Source: | Dermatology & Therapy. Jun2026, p1-20. 20p. |
| Database: | Academic Search Ultimate |
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-026-01791-1 |
